Nicholas Willumsen
Director & Head of Oncology Nordic Bioscience A/S
Seminars
Tuesday 4th November 2025
Hacking the Tumor Matrix: Non-Invasive Extracellular Matrix (ECM) Biomarkers for ADC Drug Development
2:30 pm
- Sharing how dysregulated ECM remodeling in cancer leads to the release of specific ECM turnover fragments into the bloodstream
- Discussing the doubling ADC response rates with PRO-C3: Harnessing non-invasive ECM biomarkers for enhanced tumor drug delivery
- Outlining how specific ECM-derived cleavage products have the potential to predict ADC linker cleavage, and drug release within tumors
